Agilon Health, Inc. (NYSE:AGL) Receives $37.93 Consensus Price Target from Brokerages

Agilon Health, Inc. (NYSE:AGL) has been given an average rating of “Hold” by the fifteen brokerages that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $39.4773.

Several research firms recently weighed in on AGL. Wall Street Zen raised Agilon Health from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. Citigroup lowered their price objective on Agilon Health from $21.25 to $18.75 and set a “neutral” rating on the stock in a research report on Tuesday, March 3rd. Weiss Ratings raised Agilon Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. Barclays reduced their target price on shares of Agilon Health from $25.00 to $12.50 and set an “underweight” rating for the company in a research report on Friday, February 27th. Finally, Robert W. Baird upped their price target on shares of Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th.

Agilon Health Stock Up 3.2%

Shares of AGL opened at $71.75 on Friday. The firm has a market cap of $1.20 billion, a P/E ratio of -3.33 and a beta of 2.29. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. Agilon Health has a 52 week low of $7.48 and a 52 week high of $74.69. The firm’s 50-day simple moving average is $22.77 and its 200 day simple moving average is $19.37.

Agilon Health (NYSE:AGL) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. On average, analysts forecast that Agilon Health will post -4.17 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Wealthcare Advisory Partners LLC acquired a new stake in shares of Agilon Health in the third quarter valued at approximately $26,000. LPL Financial LLC grew its position in Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after buying an additional 30,000 shares in the last quarter. Krilogy Financial LLC bought a new position in Agilon Health during the 4th quarter worth $34,000. CIBC Bancorp USA Inc. bought a new position in Agilon Health during the 3rd quarter worth $34,000. Finally, Merit Financial Group LLC acquired a new position in Agilon Health in the 4th quarter valued at $35,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.